Dr. Lorena García-Hevia is a Research Scientist at the University of Cantabria and Valdecilla Research Institute (IDIVAL). She holds a PhD in Molecular Biology, with expertise in Nanomedicine, Molecular and Cell Biology.  She continued her specialization in nanomedicine in 3 different institutes in Europe and USA. In 2016, she moved to the Stephenson Cancer Center at the University of Oklahoma, where she investigated the use of gold nanoparticles in ovarian cancer. In 2017, she got a position at one of Europe’s most prestigious international centers focused on nanoscience and nanotechnology, The International Nanotechnology Laboratory (INL), in Braga (Portugal). Her research focused on developing and validating magnetic nanostructures and solid lipid nanoparticles for cancer treatment. Two years later, in 2019, she moved to The Biorobotics Institute (Pisa, Italy) to work on a European regenerative medicine and biomaterials project. After this international experience, in 2020 she obtained one of the renowned “Sara Borrell” fellowships that she enjoyed until 2021 when she finally obtained a highly competitive Juan de la Cierva Incorporación postdoctoral contract to work as an independent researcher at the University of Cantabria. Her international vision has opened numerous collaborations that have helped her to participate in different European international COST Action networks and that have enabled her to continue traveling on short stays to different laboratories at the international level and co-chairing the organizing committee of the Nanomaterial Apply to live Science Congress (NALS 2022). She is/was involved in more than 15 National and International projects. Currently, she leads three projects, has co-authored numerous peer-reviewed publications and holds a patent.